文献速递糖尿病肥胖与代谢综合征

1型糖尿病患者中sRAGE与肥胖的关系:中位随访6.3年

Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years.
PubMed 文献 · Diabetologia · 2025-04-29

研究纳入FinnDiane研究中3886例1型糖尿病成人,中位随访6.3年,采用ELISA测定血清sRAGE。基线sRAGE与BMI和腰高比均呈负相关,且在各白蛋白尿亚组中一致;但sRAGE与随访期间BMI和腰高比的变化无关。

要点

  • 基线sRAGE与BMI呈负相关(r²=0.07,β -0.174;p<0.001)。
  • 基线sRAGE与腰高比呈负相关(r²=0.16,β -0.179;p<0.001)。
  • sRAGE与随访6.3年间BMI或腰高比的变化无关。

核心结论

  • sRAGE与代表全身性肥胖的BMI和代表中心性肥胖的腰高比均呈负相关,且独立于肾脏疾病,提示sRAGE是肥胖的生物标志物。
  • sRAGE与6.3年随访期间BMI和腰高比的变化无关。
  • 作者认为需要更长期随访的研究来理解sRAGE与体脂积累的关系。

研究设计与样本

  • 研究纳入FinnDiane研究中3886例1型糖尿病成人。
  • 血清sRAGE浓度采用ELISA测定。
  • 中心性肥胖依据腰高比定义,全身性肥胖依据BMI定义。
  • 采用Kruskal-Wallis检验比较按白蛋白尿状态分层各组间基线BMI、腰高比和sRAGE浓度的差异。
  • 采用线性回归(校正性别、年龄、白蛋白尿和HbA1c)评估基线sRAGE与肥胖指标及随时间变化的关联。

主要发现

  • 中位随访6.3年间,BMI中位变化Δ为0.76 kg/m²(IQR -0.39至2.07;p<0.001),腰高比中位变化Δ为0.019(IQR -0.007至0.05;p<0.001)。
  • 67%的个体观察到BMI变化,68%的个体观察到腰高比变化。
  • 在总体队列中,基线sRAGE与BMI呈负相关(r²=0.07,β -0.174;p<0.001),与腰高比呈负相关(r²=0.16,β -0.179;p<0.001)。
  • 按白蛋白尿状态分层(无、中度、重度白蛋白尿)的各亚组中,上述关系保持一致(所有p<0.001)。
  • sRAGE与随访期间BMI或腰高比的变化无关。

局限性

  • 作者认为需要更长期随访的研究来理解sRAGE与体脂积累的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Soluble receptor for advanced glycation end products (sRAGE) has been inversely linked to obesity, which is defined by excess of total body fat. However, body fat accumulation is also relevant for health. In this study, we investigated associations between sRAGE and obesity in individuals with type 1 diabetes over 6.3 years of follow-up. METHODS: The study included 3886 adults with type 1 diabetes from the FinnDiane study. Serum sRAGE concentrations were determined by ELISA. Central obesity was defined on the basis of waist/height ratio (WHtR), and general obesity on the basis of BMI. The Kruskal-Wallis test was used to assess the differences in baseline BMI, WHtR and sRAGE concentrations, comparing the groups stratified by albuminuria status. Changes in BMI and WHtR were calculated over time and Wilcoxon rank test was used for comparisons. Linear regression, adjusted for sex, age, albuminuria and HbA1c, was used for assessing the association of sRAGE with obesity measures at baseline, and with changes over time. RESULTS: Over a median follow-up of 6.3 years, BMI changed by a median Δ of 0.76 kg/m2 (IQR -0.39 to 2.07; p<0.001) and WHtR by a median Δ of 0.019 (IQR -0.007 to 0.05; p<0.001). The change in BMI was observed in 67% of the individuals, and WHtR in 68% of them. Baseline sRAGE was inversely associated with BMI (r2=0.07, β -0.174; p<0.001) and WHtR (r2=0.16, β -0.179; p<0.001) in the overall cohort. These relationships remained consistent across subgroups stratified by albuminuria status, including no, moderate and severe albuminuria (all p<0.001). However, sRAGE was not associated with changes in BMI or WHtR over time. CONCLUSIONS/INTERPRETATION: sRAGE is inversely associated with both general and central obesity, as represented by BMI and WHtR, independent of kidney disease, suggesting sRAGE is a biomarker of obesity. However, sRAGE is not associated with the changes in BMI and WHtR over a 6.3 year follow-up. Future research with longer follow-up is merited to understand how sRAGE correlates with body fat accumulation.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Adeshara K, Parente EB, Harjutsalo V, et al. Relationship between sRAGE and obesity in individuals with type 1 diabetes during a median follow-up of 6.3 years. Diabetologia. 2025. PMID: 40301129. doi:10.1007/s00125-025-06440-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。